These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23242281)

  • 1. Diffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration.
    Laule C; Pavlova V; Leung E; Zhao G; MacKay AL; Kozlowski P; Traboulsee AL; Li DK; Moore GR
    J Neuropathol Exp Neurol; 2013 Jan; 72(1):42-52. PubMed ID: 23242281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological basis of diffusely abnormal white matter: insights from magnetic resonance imaging and histology.
    Laule C; Vavasour IM; Leung E; Li DK; Kozlowski P; Traboulsee AL; Oger J; Mackay AL; Moore GR
    Mult Scler; 2011 Feb; 17(2):144-50. PubMed ID: 20965961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
    Seewann A; Vrenken H; van der Valk P; Blezer EL; Knol DL; Castelijns JA; Polman CH; Pouwels PJ; Barkhof F; Geurts JJ
    Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological correlates of magnetic resonance imaging texture heterogeneity in multiple sclerosis.
    Zhang Y; Moore GR; Laule C; Bjarnason TA; Kozlowski P; Traboulsee A; Li DK
    Ann Neurol; 2013 Jul; 74(1):91-9. PubMed ID: 23939554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dirty-appearing white matter in multiple sclerosis: preliminary observations of myelin phospholipid and axonal loss.
    Moore GR; Laule C; Mackay A; Leung E; Li DK; Zhao G; Traboulsee AL; Paty DW
    J Neurol; 2008 Nov; 255(11):1802-11. PubMed ID: 18821049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
    Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
    Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusely abnormal white matter in multiple sclerosis.
    Cairns J; Vavasour IM; Traboulsee A; Carruthers R; Kolind SH; Li DKB; Moore GRW; Laule C
    J Neuroimaging; 2022 Jan; 32(1):5-16. PubMed ID: 34752664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive white matter pathology in the spinal cord of transgenic mice expressing mutant (P301L) human tau.
    Lin WL; Zehr C; Lewis J; Hutton M; Yen SH; Dickson DW
    J Neurocytol; 2005 Dec; 34(6):397-410. PubMed ID: 16902761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions.
    Itoyama Y; Sternberger NH; Webster HD; Quarles RH; Cohen SR; Richardson EP
    Ann Neurol; 1980 Feb; 7(2):167-77. PubMed ID: 6154440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
    Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
    Mastronardi FG; Moscarello MA
    J Neurosci Res; 2005 May; 80(3):301-8. PubMed ID: 15704220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
    Leitner H
    Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal ubiquitination of axons in normally myelinated white matter in multiple sclerosis brain.
    Giordana MT; Richiardi P; Trevisan E; Boghi A; Palmucci L
    Neuropathol Appl Neurobiol; 2002 Feb; 28(1):35-41. PubMed ID: 11849561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-component relaxation in clinically isolated syndrome: Lesion myelination may predict multiple sclerosis conversion.
    Kitzler HH; Wahl H; Eisele JC; Kuhn M; Schmitz-Peiffer H; Kern S; Rutt BK; Deoni SCL; Ziemssen T; Linn J
    Neuroimage Clin; 2018; 20():61-70. PubMed ID: 30094157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin-associated glycoprotein in multiple sclerosis lesions: a quantitative and qualitative analysis.
    Möller JR; Yanagisawa K; Brady RO; Tourtellotte WW; Quarles RH
    Ann Neurol; 1987 Oct; 22(4):469-74. PubMed ID: 2449119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions.
    Clarner T; Diederichs F; Berger K; Denecke B; Gan L; van der Valk P; Beyer C; Amor S; Kipp M
    Glia; 2012 Oct; 60(10):1468-80. PubMed ID: 22689449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T2 Relaxometry Evidence of Microstructural Changes in Diffusely Abnormal White Matter in Relapsing-Remitting Multiple Sclerosis and Clinically Isolated Syndrome: Impact on Visuomotor Performance.
    Papadaki E; Mastorodemos V; Panou T; Pouli S; Spyridaki E; Kavroulakis E; Kalaitzakis G; Maris TG; Simos P
    J Magn Reson Imaging; 2021 Oct; 54(4):1077-1087. PubMed ID: 33960066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.
    Anderson TD; Davidovich A; Feldman D; Sprinkle TJ; Arezzo J; Brosnan C; Calderon RO; Fossom LH; DeVries JT; DeVries GH
    Lab Invest; 1994 May; 70(5):724-39. PubMed ID: 7515130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis.
    Vos CM; Geurts JJ; Montagne L; van Haastert ES; Bö L; van der Valk P; Barkhof F; de Vries HE
    Neurobiol Dis; 2005 Dec; 20(3):953-60. PubMed ID: 16039866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.